ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

NCI CTEP Approved Trials For the Month of September

September 27, 2013

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979